RTP Mobile Logo
ONUL117

 

Track 1: Clinical care of patients with lung cancer amid the COVID-19 pandemic — Dr Liu
Track 2: Case (Dr Liu): A woman in her early 60s with Stage IV non-small cell lung cancer (NSCLC) and an EGFR exon 19 deletion receives osimertinib as first-line therapy and develops COVID-19
Track 3: Case (Dr Liu): A woman in her mid-60s with severe dyspnea is diagnosed with small cell lung cancer and COVID-19
Track 4: Case (Dr Liu): A man in his early 60s presents with metastatic NSCLC and an EGFR mutation
Track 5: Risk of complications with immunotherapy and chemotherapy during the COVID-19 pandemic
Track 6: Impact of COVID-19 on the care of patients with lung cancer; role of telemedicine
Track 7: Long-term effects of COVID-19 on clinical research and new advances
Track 8: Treatment of breast cancer during the COVID-19 pandemic — Dr Traina
Track 9: Case (Dr Traina): A woman in her mid-60s receiving treatment for HER2-positive metastatic breast cancer tests positive for COVID-19
Track 10: Case (Dr Traina): A woman in her early 50s with triple-negative breast cancer experiences severe symptoms with COVID-19
Track 11: Effect of the pandemic on palliative care; novel agents and management approaches for patients with COVID-19
Track 12: Patterns of cancer treatment during the pandemic
Track 13: Role of telemedicine in the monitoring and care of patients with cancer
Track 14: Gastrointestinal cancers in the COVID-19 era — Dr Bekaii-Saab
Track 15: Case (Dr Bekaii-Saab): A woman in her early 60s with pancreatic neuroendocrine cancer and liver metastases develops COVID-19
Track 16: Case (Dr Bekaii-Saab): A man in his early 70s receiving FOLFIRI/binimetinib for microsatellite stable, RAS/RAF wild-type colon cancer recovers after severe COVID-19
Track 17: Changes in patterns of care for patients with gastrointestinal cancers during the COVID-19 pandemic
Track 18: Challenges with the use of chemotherapy and immunotherapy for patients with cancer in the COVID-19 era
Track 19: Management of genitourinary cancers during the COVID-19 era — Dr Oh
Track 20: Case (Dr Oh): A man in his early 80s with metastatic castration-resistant prostate cancer tests positive for SARs-CoV-2
Track 21: Case (Dr Oh): A man in his early 70s is diagnosed with metastatic renal cell carcinoma amid the COVID-19 pandemic
Track 22: Risk factors for complications from COVID-19; emerging mechanism for the protective effects of androgen deprivation therapy
Track 23: Impact of the pandemic on the care of patients with genitourinary cancers
Track 24: Effects of COVID-19 on the care of patients with cancer and on cancer research
Track 25: New advances and emerging options for the management of COVID-19
 
FACULTY
 
Tanios Bekaii-Saab, MD
Professor, Mayo Clinic College of Medicine and Science
Program Leader, Gastrointestinal Cancer, Mayo Clinic Cancer Center
Consultant, Mayo Clinic in Arizona
Phoenix, Arizona
 
Stephen V Liu, MD, PhD
Associate Professor of Medicine
Georgetown University Hospital
Washington, DC
 
William K Oh, MD
Chief, Division of Hematology and Medical Oncology
Professor of Medicine and Urology
Ezra M Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research
The Tisch Cancer Institute
Mount Sinai Health System
New York, New York
 
Tiffany A Traina, MD
Vice Chair, Department of Medicine
Associate Attending Physician
Section Head, Triple-Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medicine
New York, New York
 
EDITOR
 
Neil Love, MD
Research To Practice
Miami, Florida